Brief: Eql Pharma AB Says Qtrly Consolidated Sales Amounted To Sek 78.1(60.3)Million, An Increase Of 30%

EQL Pharma AB

14/05/2024 19:18

May 14 (Reuters) - EQL Pharma AB  EQL.TE :
    * QTRLY CONSOLIDATED SALES AMOUNTED TO SEK
78.1(60.3)MILLION, AN
INCREASE OF 30%
    * QTRLY EBIT AMOUNTED TO SEK 8.4 (6.1) MILLION, AN INCREASE
OF 38%
    * QTRLY EBITDA MARGIN WAS 14%
    * FOR FISCAL YEAR 2024/25, CO ANTICIPATES GROWTH RATE OF
AROUND
40%, WITH A TARGET EBITDA MARGIN OF MORE THAN 25%

Source text for Eikon:  ID:nWkrbkgXBw 
Further company coverage:  EQL.TE 

 ((Reuters.Briefs@thomsonreuters.com;))